Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Indefinite Delivery Contract HHSO100201300009I
Award Date
9/9/13
Last Date to Order
9/7/23
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
2
Activity
6
Contract IDVs
Contract Awards
2
Transactions
6
Price Lists
Opportunity Stack
1
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Cangene Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Federal Contract Vehicle
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
HHSO100201300009I
Indefinite Delivery Contract
2
Federal Contract Awards
Description
Update #1
Posted 9/6/13, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00005
BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR), DEPARTMENT OF HEALTH AND HUMAN SERVICES, EXTENDED STORAGE OF PLASMA AND OPTIONAL CONVERSION TO FDP OF A LICENSED ANTHRAX ANTITO
Supplemental Agreement for work within scope
$0
12/5/21
4
Other Administrative Action
$0
12/4/17
3
CANGENE CORP.
Other Administrative Action
$0
12/11/14
2
CANGENE CORP.
Other Administrative Action
$0
4/15/14
1
Other Administrative Action
$0
9/12/13
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order HHSO100201300009I-75A50118F33002
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Delivery Order contract to Cangene Corporation, a for-profit organization, with a potential value of $1,457,107.00. The contract has a period of performance ending on July 31, 2025 and was awarded on August 29, 2018. The contract does not have a set-aside designation. The place of performance is located in Ottawa, Ontario, Canada.
Cangene Corporation
$1.5m
8/29/18
7/31/25
9/7/23
Delivery Order HHSO100201300009I-HHSO10033001T
Cangene Corporation
$63.3m
9/16/13
9/8/18
4/15/14
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Anthrax Antitoxins for the Treatment of Inhalational Anthrax
Added: Jun 15, 2012 3:26 pm The Department of Health and Human Services (HHS) has the responsibility of maintaining a definitive supply of medical countermeasures - or the forward deployment of same - for use in national medical emergencies declared by the Secretary of HHS. HHS has a requirement to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological threat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anthrax antitoxin products to treat individuals with symptomatic anthrax disease resulting from aerosol release of Bacillus anthracis (B. anthracis) spores.
RFP-12-100-SOL-00026
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 1/1
6/15/12, 3:26 PM